Khosla Ventures Doubles Down on Even Healthcare at $300M Valuation to Disrupt India Hospital Model

TL;DR

• Even Healthcare has reportedly hit a $300 million valuation in a new funding round led by Khosla Ventures, marking a major vote of confidence in its subscription-led managed care model.
• The Bengaluru-based startup plans to use the fresh capital to expand its own Even-branded hospitals across India, challenging traditional fee-for-service hospital economics.
• Khosla's continued backing signals growing Silicon Valley interest in India's healthcare delivery overhaul, as Even targets profitability and national scale.

Khosla's Big Bet on Indian Healthcare

Even Healthcare is back in the spotlight. The Bengaluru-based healthtech startup has hit a $300 million valuation in a new funding round led by Khosla Ventures, according to reports circulating this week. The round marks a sharp step-up for the company and cements Khosla as its most high-profile backer in a crowded Indian healthtech market.

While Even has not officially disclosed the full round size, sources indicate Khosla Ventures led the raise with participation from existing investors. The deal is seen as a doubling down by the Silicon Valley firm, which has been increasingly bullish on AI-led healthcare disruption in India and the U.S.

Why Khosla Is Betting Big

For Khosla Ventures, Even fits a familiar thesis: use technology and aligned incentives to fix a broken system. Vinod Khosla has long argued that the traditional hospital model incentivizes volume over outcomes, leading to over-billing, unnecessary procedures, and poor preventive care.

Even flips that script. Instead of paying per visit or procedure, members pay a flat subscription for unlimited primary care, diagnostics, and specialist consults, with hospitalizations covered up to a limit. By acting as both payer and provider, Even says it can keep patients healthier while keeping costs down — a model Khosla has publicly praised as the future of care delivery.

How Even Aims to Challenge Traditional Hospital Economics

At the heart of Even's playbook is owning the full stack. Unlike aggregators that simply partner with clinics, Even is building and operating its own Even-branded hospitals.

The company opened its first tech-enabled hospital in Bengaluru and claims significantly higher operational efficiency, shorter wait times, and transparent pricing compared to legacy hospital chains like Apollo and Fortis. By integrating its membership base, in-house doctors, electronic health records, and its Even app, it aims to cut administrative waste and reduce reliance on insurance middlemen.

Executives have said this full-stack approach allows Even to reinvest savings into preventive care and chronic disease management, rather than profiting from sick beds.

Aggressive Growth Plans Across India

The new capital will fuel an aggressive hospital network expansion. Even plans to launch multiple new hospitals in Bengaluru, Hyderabad, Delhi NCR, and Mumbai over the next 18 to 24 months, while scaling its primary care clinic footprint.

The startup, founded in 2020 by Mayank Banerjee, Matilde Giglio, and Alessandro Ialongo, now serves hundreds of thousands of members, largely through employer partnerships with startups and large enterprises. It aims to cross a million paid members as it expands geographically.

What It Means for Indian Healthcare

India's hospital sector, valued at over $90 billion, remains dominated by fee-for-service chains and out-of-pocket spending. Even's rise comes at a time when middle-class Indians are frustrated with opaque billing, rising insurance premiums, and rushed consultations.

If Even can prove that managed, subscription-based care delivers better outcomes at lower cost — and do it profitably at scale — it could force incumbents to rethink pricing and patient experience. Analysts say the $300 million valuation reflects not just growth, but belief that Even could become India's answer to Kaiser Permanente.

What's Next

The key test will be execution. Running hospitals is capital-intensive and operationally complex, far different from running a digital subscription product. Questions remain around unit economics, clinical quality at scale, and regulatory navigation.

Still, with Khosla Ventures now doubling down at a $300 million valuation, Even has both the war chest and the Silicon Valley halo to take on India's hospital giants head-on.

AndroGuider Team

Articles written by the AndroGuider team. We try to make them thorough and informational while being easy to read.